• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和低亮度下年龄相关性黄斑变性眼的自动化定量对比敏感度评估。

Normal- and Low-Luminance Automated Quantitative Contrast Sensitivity Assessment in Eyes With Age-Related Macular Degeneration.

机构信息

Retina Foundation of the Southwest (W.C.O., A.H.C., R.A.D., K.G.C.), Dallas, Texas.

and Adaptive Sensory Technology, Inc (L.A.L.), San Diego, California, USA.

出版信息

Am J Ophthalmol. 2021 Jun;226:148-155. doi: 10.1016/j.ajo.2021.01.017. Epub 2021 Jan 30.

DOI:10.1016/j.ajo.2021.01.017
PMID:33529583
Abstract

PURPOSE

To assess the effectiveness of an active learning approach to measuring the contrast sensitivity function (CSF) in patients with various degrees of dry age-related macular degeneration (AMD) under multiple luminance conditions.

DESIGN

Cross-sectional study.

METHODS

Patients with AMD (26 intermediate AMD, 19 AMD with subretinal drusenoid deposits [SDD], 20 geographic atrophy [GA]) and 23 age-matched controls were tested with the Manifold Contrast Vision Meter (Adaptive Sensory Technology) and the qCSF algorithm, which applies active learning to estimate a model of the CSF's global shape. Testing was performed under conditions of standard and low luminance. For each AMD severity, the area under log CSF (AULCSF) and contrast sensitivities at individual spatial frequencies were calculated for analysis. Low-luminance deficits (LLDs) for visual acuity (VA) and AULCSF were calculated as the difference between standard and low luminance values.

RESULTS

Progressive decreases in AULCSF were observed as disease severity increased. For standard luminance, pairwise comparisons revealed significant differences between control/intermediate AMD (P < .0005), control/SDD (P < .0005), control/GA (P < .0005), and intermediate AMD/GA (P < .005). Similarly, for low luminance, pairwise comparisons revealed significant differences between the controls and each disease group (all P < .0005), in addition to significant differences between intermediate AMD/SDD (P < .005), and intermediate AMD/GA (P < .005). No correlations were found between LLD VA and LLD AULCSF in any AMD groups.

CONCLUSIONS

Contrast sensitivity measured via qCSF under both standard- and low-luminance conditions correlates with advancing stages of dry AMD. The interaction between luminance and contrast sensitivity appears to reflect a different aspect of visual function than the interaction between luminance and VA.

摘要

目的

评估主动学习方法在不同程度干性年龄相关性黄斑变性(AMD)患者在多种亮度条件下测量对比敏感度功能(CSF)的效果。

设计

横断面研究。

方法

使用多维对比视力计(自适应感觉技术)和 qCSF 算法对 AMD 患者(26 例中度 AMD、19 例 AMD 伴视网膜下类脂沉积[SDD]、20 例地图状萎缩)和 23 名年龄匹配的对照者进行测试,qCSF 算法采用主动学习来估计 CSF 整体形状的模型。在标准和低亮度条件下进行测试。对于每个 AMD 严重程度,计算对数 CSF(AULCSF)的面积和个别空间频率的对比敏感度进行分析。计算视力(VA)和 AULCSF 的低亮度缺陷(LLD)作为标准和低亮度值之间的差值。

结果

随着疾病严重程度的增加,AULCSF 逐渐降低。对于标准亮度,对照组/中度 AMD(P <.0005)、对照组/SDD(P <.0005)、对照组/GA(P <.0005)和中度 AMD/GA(P <.005)之间存在显著差异。同样,对于低亮度,对照组与每个疾病组之间存在显著差异(均 P <.0005),中度 AMD/SDD(P <.005)和中度 AMD/GA(P <.005)之间也存在显著差异。在任何 AMD 组中,LLD VA 与 LLD AULCSF 之间均无相关性。

结论

在标准和低亮度条件下通过 qCSF 测量的对比敏感度与干性 AMD 的进展阶段相关。亮度和对比敏感度之间的相互作用似乎反映了视觉功能的一个不同于亮度和 VA 之间的相互作用的方面。

相似文献

1
Normal- and Low-Luminance Automated Quantitative Contrast Sensitivity Assessment in Eyes With Age-Related Macular Degeneration.正常和低亮度下年龄相关性黄斑变性眼的自动化定量对比敏感度评估。
Am J Ophthalmol. 2021 Jun;226:148-155. doi: 10.1016/j.ajo.2021.01.017. Epub 2021 Jan 30.
2
Association of Low Luminance Questionnaire With Objective Functional Measures in Early and Intermediate Age-Related Macular Degeneration.低亮度问卷与早期和中期年龄相关性黄斑变性的客观功能测量的相关性。
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):289-297. doi: 10.1167/iovs.17-22528.
3
Spatial Dissociation of Subretinal Drusenoid Deposits and Impaired Scotopic and Mesopic Sensitivity in AMD.AMD 中视网膜下玻璃膜疣沉积的空间分离与暗适应和中间视觉敏感度下降。
Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):32. doi: 10.1167/iovs.63.2.32.
4
Low-luminance visual acuity and microperimetry in age-related macular degeneration.年龄相关性黄斑变性的低亮度视力和微视野检查。
Ophthalmology. 2014 Aug;121(8):1612-9. doi: 10.1016/j.ophtha.2014.02.005. Epub 2014 Mar 22.
5
Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.早期和中期干性年龄相关性黄斑变性的视觉功能指标作为临床试验终点的应用。
Am J Ophthalmol. 2018 May;189:127-138. doi: 10.1016/j.ajo.2018.02.012. Epub 2018 Mar 15.
6
Comparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular Health.年龄相关性黄斑变性最早阶段老年眼的视觉功能与正常黄斑健康者视觉功能的比较。
Curr Eye Res. 2016;41(2):266-72. doi: 10.3109/02713683.2015.1011282. Epub 2015 Mar 24.
7
Visual function assessment in simulated real-life situations in patients with age-related macular degeneration compared to normal subjects.与正常受试者相比,年龄相关性黄斑变性患者在模拟现实生活场景中的视觉功能评估。
Eye (Lond). 2014 Oct;28(10):1231-8. doi: 10.1038/eye.2014.189. Epub 2014 Aug 1.
8
Association of Visual Function Measures with Drusen Volume in Early Stages of Age-Related Macular Degeneration.年龄相关性黄斑变性早期阶段中视功能测量与玻璃膜疣体积的相关性。
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):55. doi: 10.1167/iovs.61.3.55.
9
Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration.年龄相关性黄斑变性的微视野和低亮度视力的纵向变化。
JAMA Ophthalmol. 2015 Apr;133(4):442-8. doi: 10.1001/jamaophthalmol.2014.5963.
10
Low luminance deficit and night vision symptoms in intermediate age-related macular degeneration.中度年龄相关性黄斑变性中的低亮度缺陷与夜视症状
Br J Ophthalmol. 2016 Mar;100(3):395-8. doi: 10.1136/bjophthalmol-2015-306621. Epub 2015 Aug 6.

引用本文的文献

1
Investigating Macular Tissue Integrity Index as a Novel Biomarker in Geographic Atrophy.研究黄斑组织完整性指数作为地图状萎缩的一种新型生物标志物。
Ophthalmol Sci. 2025 Jun 30;5(6):100871. doi: 10.1016/j.xops.2025.100871. eCollection 2025 Nov-Dec.
2
Exploiting Microperimetry as a Functional End Point in Healthy Aging and Different Stages of Age-Related Macular Degeneration.利用微视野检查作为健康衰老和不同阶段年龄相关性黄斑变性的功能终点。
Ophthalmol Sci. 2025 Jun 10;5(6):100850. doi: 10.1016/j.xops.2025.100850. eCollection 2025 Nov-Dec.
3
Using Hierarchical Bayesian Modeling to Enhance Statistical Inference on Contrast Sensitivity.
使用分层贝叶斯建模增强对比敏感度的统计推断。
Transl Vis Sci Technol. 2024 Dec 2;13(12):17. doi: 10.1167/tvst.13.12.17.
4
Predicting contrast sensitivity functions with digital twins.用数字孪生技术预测对比敏感度函数。
Sci Rep. 2024 Oct 15;14(1):24100. doi: 10.1038/s41598-024-73859-x.
5
A Novel Artificial Intelligence-Based Classification of Highly Myopic Eyes Based on Visual Function and Fundus Features.一种基于视觉功能和眼底特征的新型人工智能高度近视眼分类方法。
Transl Vis Sci Technol. 2024 Sep 3;13(9):12. doi: 10.1167/tvst.13.9.12.
6
Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures.糖尿病视网膜病变患者的视觉功能测量:关于现有测量方法的专家意见
Ophthalmol Sci. 2024 Apr 6;4(5):100519. doi: 10.1016/j.xops.2024.100519. eCollection 2024 Sep-Oct.
7
Correlation of contrast sensitivity with ganglion cell/inner plexiform layer thickness and damage location in glaucoma with varying severity.对比敏感度与不同严重程度青光眼的神经节细胞/内丛状层厚度和损伤位置的相关性。
Eye (Lond). 2024 May;38(7):1308-1313. doi: 10.1038/s41433-023-02887-0. Epub 2023 Dec 15.
8
Test-retest repeatability and agreement of the quantitative contrast sensitivity function test: towards the validation of a new clinical endpoint.定量对比敏感度功能测试的重测重复性和一致性:新临床终点的验证。
Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):813-822. doi: 10.1007/s00417-023-06291-y. Epub 2023 Nov 13.
9
Evaluating Contrast Sensitivity in Early and Intermediate Age-Related Macular Degeneration With the Quick Contrast Sensitivity Function.使用快速对比敏感度函数评估早期和中期年龄相关性黄斑变性的对比敏感度。
Invest Ophthalmol Vis Sci. 2023 Nov 1;64(14):7. doi: 10.1167/iovs.64.14.7.
10
Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration.中年年龄相关性黄斑变性进展的生物标志物
Ophthalmol Ther. 2023 Dec;12(6):2917-2941. doi: 10.1007/s40123-023-00807-9. Epub 2023 Sep 29.